$154 Million is the total value of Invus Financial Advisors, LLC's 8 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 11.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CPNG | Sell | Coupang Inccl a | $35,945,136 | -11.7% | 2,246,571 | -18.8% | 23.41% | +8.1% |
RCUS | Arcus Biosciences Inc | $29,404,284 | -11.8% | 1,612,077 | 0.0% | 19.15% | +8.0% | |
TBLA | Buy | Taboola.com Ltd | $27,117,026 | +12.6% | 9,969,495 | +27.5% | 17.66% | +37.8% |
Nu Hldgs Ltd | $26,574,842 | +17.0% | 5,582,950 | 0.0% | 17.31% | +43.2% | ||
NVCR | Novocure Ltd | $21,102,164 | -18.0% | 350,884 | 0.0% | 13.74% | +0.4% | |
IONQ Inc | $6,150,000 | +78.3% | 1,000,000 | 0.0% | 4.01% | +118.2% | ||
ORIC | Oric Pharmaceuticals Inc | $5,743,178 | -3.2% | 1,007,575 | 0.0% | 3.74% | +18.5% | |
IHS Holding Limited | $1,494,088 | +42.4% | 170,558 | 0.0% | 0.97% | +74.4% | ||
OYST | Exit | Oyster Point Pharma Inc | $0 | – | -2,768,586 | -100.0% | -16.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Arcus Biosciences Inc | 16 | Q3 2023 | 24.7% |
Novocure Ltd | 16 | Q3 2023 | 25.4% |
Oric Pharmaceuticals Inc | 14 | Q3 2023 | 14.3% |
Oyster Point Pharma Inc | 13 | Q4 2022 | 44.5% |
Coupang Inc | 11 | Q3 2023 | 51.6% |
Taboola.com Ltd | 10 | Q3 2023 | 23.7% |
Unity Biotechnology Inc | 9 | Q4 2021 | 8.0% |
Yext Inc | 8 | Q3 2021 | 30.3% |
IONQ Inc | 8 | Q3 2023 | 7.2% |
Nu Hldgs Ltd | 6 | Q3 2023 | 25.4% |
View Invus Financial Advisors, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Invus Financial Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.